Recurrent pregnancy loss evaluation combined with 24-chromosome microarray of miscarriage tissue provides a probable or definite cause of pregnancy loss in over 90% of patients
Open accessThe DOI matches its Crossref record; 45 of the 46 references it cites were found in a registry or an index.
Abstract
STUDY QUESTION: Will the addition of 24-chromosome microarray analysis on miscarriage tissue combined with the standard American Society for Reproductive Medicine (ASRM) evaluation for recurrent miscarriage explain most losses? SUMMARY ANSWER: Over 90% of patients with recurrent pregnancy loss (RPL) will have a probable or definitive cause identified when combining genetic testing on miscarriage tissue with the standard ASRM evaluation for recurrent miscarriage. WHAT IS KNOWN ALREADY: RPL is estimated to occur in 2-4% of reproductive age couples. A probable cause can be identified in approximately 50% of patients after an ASRM recommended workup including an evaluation for parental chromosomal abnormalities, congenital and acquired uterine anomalies, endocrine imbalances and autoimmune factors including antiphospholipid syndrome. STUDY DESIGN, SIZE, DURATION: Single-center, prospective cohort study that included 100 patients seen in a private RPL clinic from 2014 to 2017. All 100 women had two or more pregnancy losses, a complete evaluation for RPL as defined by the ASRM, and miscarriage tissue evaluated by 24-chromosome microarray analysis after their second or subsequent miscarriage. PARTICIPANTS/MATERIALS, SETTING, METHODS: Frequencies of abnormal results for evidence-based diagnostic tests considered definite or probable causes of RPL (karyotyping for parental chromosomal abnormalities, and 24-chromosome microarray evaluation for products of conception (POC); pelvic sonohysterography, hysterosalpingogram, or hysteroscopy for uterine anomalies; immunological tests for lupus anticoagulant and anticardiolipin antibodies; and blood tests for thyroid stimulating hormone (TSH), prolactin and hemoglobin A1c) were evaluated. We excluded cases where there was maternal cell contamination of the miscarriage tissue or if the ASRM evaluation was incomplete. A cost analysis for the evaluation of RPL was conducted to determine whether a proposed procedure of 24-chromome microarray evaluation followed by an ASRM RPL workup (for those RPL patients who had a normal 24-chromosome microarray evaluation) was more cost-efficient than conducting ASRM RPL workups on RPL patients followed by 24-chromosome microarray analysis (for those RPL patients who had a normal RPL workup). MAIN RESULTS AND THE ROLE OF CHANCE: A definite or probable cause of pregnancy loss was identified in the vast majority (95/100; 95%) of RPL patients when a 24-chromosome pair microarray evaluation of POC testing is combined with the standard ASRM RPL workup evaluation at the time of the second or subsequent loss. The ASRM RPL workup identified an abnormality and a probable explanation for pregnancy loss in only 45/100 or 45% of all patients. A definite abnormality was identified in 67/100 patients or 67% when initial testing was performed using 24-chromosome microarray analyses on the miscarriage tissue. Only 5/100 (5%) patients, who had a euploid loss and a normal ASRM RPL workup, had a pregnancy loss without a probable or definitive cause identified. All other losses were explained by an abnormal 24-chromosome microarray analysis of the miscarriage tissue, an abnormal finding of the RPL workup, or a combination of both. Results from the cost analysis indicated that an initial approach of using a 24-chromosome microarray analysis on miscarriage tissue resulted in a 50% savings in cost to the health care system and to the patient. LIMITATIONS, REASONS FOR CAUTION: This is a single-center study on a small group of well-characterized women with RPL. There was an incomplete follow-up on subsequent pregnancy outcomes after evaluation, however this should not affect our principal results. The maternal age of patients varied from 26 to 45 years old. More aneuploid pregnancy losses would be expected in older women, particularly over the age of 35 years old. WIDER IMPLICATIONS OF THE FINDINGS: Evaluation of POC using 24-chromosome microarray analysis adds significantly to the ASRM recommended evaluation of RPL. Genetic evaluation on miscarriage tissue obtained at the time of the second and subsequent pregnancy losses should be offered to all couples with two or more consecutive pregnancy losses. The combination of a genetic evaluation on miscarriage tissue with an evidence-based evaluation for RPL will identify a probable or definitive cause in over 90% of miscarriages. STUDY FUNDING/COMPETING INTEREST(S): No funding was received for this study and there are no conflicts of interest to declare. TRIAL REGISTRATION NUMBER: Not applicable.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Other than the prognostic advantages, when used in combination with routine investigations into recurrent miscarriage, cytogenetic analysis of the pregnancy tissue have shown to provide a diagnosis in over 90% of couples.137”
From Recurrent MiscarriageGreen‐top Guideline No. 17 (2023) · cites this paper as [137]
Citations
Cites
1 retracted
RETIRED: Technical Update: Preimplantation Genetic Diagnosis and Screening
Dahdouh, E. M., Balayla, J., Audibert, F., Wilson, R. D., Audibert, F., Brock, J., Campagnolo, C., Carroll, J. C., Chong, K., Gagnon, A. L., et al. (2015) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(15)30261-9 · Cited by 107
RetractedChromosomal microarray versus karyotyping for prenatal diagnosis
Wapner, R. J., Martin, C. L., Levy, B., Ballif, B. C., Eng, C. M., Zachary, J. M., Savage, M., Platt, L. D., Saltzman, D., Grobman, W. A., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1203382 · Cited by 1,412 · cited 1×
“Previous investigators have demonstrated that the detection of genetic abnormalities in miscarriage tissue is significantly improved by CMA analysis compared to standard karyotype (Reddy et al., 2012; Wapner et al., 2012; Lo et al., 2014).”
BackgroundEvaluation and treatment of recurrent pregnancy loss: a committee opinion
(2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2012.06.048 · Cited by 1,308
Thrombophilic disorders and fetal loss: a meta-analysis
Rey, E., Kahn, S. R., David, M., & Shrier, I. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12771-7 · Cited by 872
A cytogenetic study of 1000 spontaneous abortions
HASSOLD, T., CHEN, N., FUNKHOUSER, J., JOOSS, T., MANUEL, B., MATSUURA, J., MATSUYAMA, A., WILSON, C., Yamane, J. A., & JACOBS, P. A. (1980) · Annals of Human Genetics · doi:10.1111/j.1469-1809.1980.tb00955.x · Cited by 676
Retrospective and prospective epidemiological studies of 1500 karyotyped spontaneous human abortions
Boué, J., Boué, A., & Lazar, P. (1975) · Teratology · doi:10.1002/tera.1420120103 · Cited by 661
Evidence-based guidelines for the investigation and medical treatment of recurrent miscarriage
Jauniaux, E. (2006) · Human Reproduction · doi:10.1093/humrep/del150 · Cited by 520 · cited 2×
“Although the presence of a particular abnormal test result does not prove that it caused the pregnancy losses in these patients, abnormalities in parental genetics, uterine anatomy, lupus anticoagulant, anticardiolipin antibodies, TSH and hemoglobin A1c are considered either probable or definite causes of RPL (Christi…”
BackgroundStray-Pedersen, B., & Stray-Pedersen, S. (1984) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(84)80164-7 · Cited by 483
Human aneuploidy: Incidence, origin, and etiology
Hassold, T., Abruzzo, M., Adkins, K., Griffin, D., Merrill, M., Millie, E., Saker, D., Shen, J., & Zaragoza, M. (1996) · Environmental and Molecular Mutagenesis · doi:10.1002/(sici)1098-2280(1996)28:3<167::aid-em2>3.0.co;2-b · Cited by 456
Frequency of factors associated with habitual abortion in 197 couples
Daya, S., & Stephenson, M. D. (1996) · Fertility and Sterility · doi:10.1016/s0015-0282(16)58382-4 · Cited by 428
Research works printed but not linked: 2
- Brezina, 2013, Clinical Reproductive Medicine and Surgery: A Practical Guide, 1
- Moraes, 2005, Cytogenetic and molecular evaluation of spontaneous abortion samples, Rev Bras Ginecol Obstet, 27, 554
Cited by
Dimitriadis, E., Menkhorst, E., Saito, S., Kutteh, W. H., & Brosens, J. J. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-00228-z · Cited by 702
Self-citationChavez-Badiola, A., Flores-Saiffe-Farías, A., Mendizabal-Ruiz, G., Drakeley, A. J., & Cohen, J. (2020) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2020.07.003 · Cited by 168
Sato, T., Sugiura-Ogasawara, M., Ozawa, F., Yamamoto, T., Kato, T., Kurahashi, H., Kuroda, T., Aoyama, N., Kato, K., Kobayashi, R., et al. (2019) · Human Reproduction · doi:10.1093/humrep/dez229 · Cited by 161
Recurrent MiscarriageGreen‐top Guideline No. 17
Regan, L., Rai, R., Saravelos, S., Li, T., & the Royal College of Obstetricians and Gynaecologists (2023) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.17515 · Cited by 158
Ghafourian, M., Mahdavi, R., Jonoush, Z. A., Sadeghi, M., Ghadiri, N., Farzaneh, M., & Salehi, A. M. (2022) · Cell Communication and Signaling · doi:10.1186/s12964-022-00853-z · Cited by 141
Diminished ovarian reserve in recurrent pregnancy loss: a systematic review and meta-analysis
Bunnewell, S., Honess, E. R., Karia, A. M., Keay, S. D., Wattar, B. H. A., & Quenby, S. M. (2020) · Fertility and Sterility · doi:10.1016/j.fertnstert.2019.11.014 · Cited by 115
Genome Sequencing Explores Complexity of Chromosomal Abnormalities in Recurrent Miscarriage
Dong, Z., Yan, J., Xu, F., Yuan, J., Jiang, H., Wang, H., Chen, H., Zhang, L., Ye, L., Xu, J., et al. (2019) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2019.10.003 · Cited by 105
Modern management of recurrent miscarriage
Homer, H. A. (2018) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/ajo.12920 · Cited by 102
Prevalence of chromosomal alterations in first-trimester spontaneous pregnancy loss
Essers, R., Лебедев, И. Н., Kurg, A., Фонова, Е. А., Stevens, S. J. C., Koeck, R. M., von Rango, U., Brandts, L., Deligiannis, S. P., Tv, N., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02645-5 · Cited by 94
“We emphasize the importance of reaching an international consensus on the clinical definition of RPL, which is the topic of an ongoing debate and differs across guidelines and countries 1,56 .”
InfluentialGenetic abnormalities and pregnancy loss
Blue, N. R., Pagé, J., & Silver, R. M. (2018) · Seminars in Perinatology · doi:10.1053/j.semperi.2018.12.002 · Cited by 82
“Of the remaining 55, 50 (90%) had a likely cause identified using microarray.(33) A total of 67/100 had a clinically relevant abnormality identified by microarray.”
Immunotherapy for recurrent pregnancy loss
Carp, H. (2019) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2019.07.005 · Cited by 73
Zhu, Y., Liu, Q., Liao, M., Diao, L., Wu, T., Liao, W., Wang, Z., Li, B., Zhang, S., Wang, S., et al. (2019) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2019.09.017 · Cited by 67
“Miscarriage, also called spontaneous abortion, can be defined as a pregnancy that terminates spontaneously before 20 weeks of gestation or a fetal weight of less than 500 g and affects 10%–15% of pregnant women.(14) It is one of the most common complications of early pregnancy.”
BackgroundReproductive outcomes in individuals with chromosomal reciprocal translocations
Verdoni, A. M., Hu, J., Surti, U., Babcock, M., Sheehan, E., Clemens, M. M., Drewes, S., Walsh, L. K., Clark, R., Katari, S., et al. (2021) · Genetics in Medicine · doi:10.1038/s41436-021-01195-w · Cited by 59
Khalife, D., Ghazeeri, G. S., & Kutteh, W. H. (2018) · Seminars in Perinatology · doi:10.1053/j.semperi.2018.12.008 · Cited by 58
Self-citationDecreased USP2a Expression Inhibits Trophoblast Invasion and Associates With Recurrent Miscarriage
Wang, J., Ding, J., Zhang, S., Chen, X., Yan, S., Zhang, Y., & Yin, T. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.717370 · Cited by 60
Papas, R. S., & Kutteh, W. H. (2020) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0000000000000647 · Cited by 53
Self-citationMümüşoğlu, S., Telek, S. B., & Ata, B. (2024) · Fertility and Sterility · doi:10.1016/j.fertnstert.2024.08.326 · Cited by 47
Youssef, A., Lashley, L., Dieben, S. W. M., Verburg, H. J., & van der Hoorn, M. (2020) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2020.05.016 · Cited by 45
Morales, C. (2023) · Reproductive Sciences · doi:10.1007/s43032-023-01301-0 · Cited by 49
“It can have several etiologies including parents carrying a chromosomal abnormality, uterine abnormalities, autoimmune or hormonal disorders, infections, or thrombophilic factors [77, 78].”
Maternal‐fetal immunity and recurrent spontaneous abortion
Yao, Y., Ye, Y., Chen, J., Zhang, M., Cai, X. T., & Zheng, C. (2024) · American Journal of Reproductive Immunology · doi:10.1111/aji.13859 · Cited by 44
Robbins, S. M., Thimm, M. A., Valle, D. L., & Jelin, A. C. (2019) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-019-01499-6 · Cited by 40
The Progress of Research on Genetic Factors of Recurrent Pregnancy Loss
Li, Q., Chen, S., Dong, X., Fu, S., Zhang, T., Zheng, W., Tian, Y., & Huang, D. (2023) · Genetics Research · doi:10.1155/2023/9164374 · Cited by 42
Karyotype evaluation of repeated abortions in primary and secondary recurrent pregnancy loss
Tv, N., Sazhenova, E. A., Жигалина, Д. И., Tolmacheva, E. N., Sukhanova, N. N., & Лебедев, И. Н. (2020) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-020-01703-y · Cited by 36
Papas, R. S., & Kutteh, W. H. (2021) · The Application of Clinical Genetics · doi:10.2147/tacg.s320778 · Cited by 33
“Also, by providing an explanation for the loss in more than 90% of couples, this approach has the potential to bring improved and important closure and psychological relief for couples dealing with RPL, compared to regular ASRM work-up where more than 50% of cases remain “unexplained”.(6,7) This proposed evaluation wa…”
BackgroundMethodSelf-citationYaron, Y., Pauta, M., Bádenas, C., Soler, A., Borobio, V., Illanes, C., y Miño, F. P., Martinez-Portilla, R. J., & BORRELL, A. (2020) · Human Reproduction · doi:10.1093/humrep/deaa073 · Cited by 35
Alipour, M., Abtin, M., Hosseinzadeh, A., & Maleki, M. (2019) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-019-01573-z · Cited by 35
“RPL is a distressful experience which affects approximately 1–5% of couples trying to conceive [3].”
BackgroundCurrent management of recurrent pregnancy loss
Chester, M. R., Tirlapur, A. S., & Jayaprakasan, K. M. (2022) · The Obstetrician & Gynaecologist · doi:10.1111/tog.12832 · Cited by 38
Cytogenetic signatures of recurrent pregnancy losses
Yatsenko, S. A., Quesada‐Candela, C., Saller, D. N., Beck, S., Jaffe, R., Kostadinov, S., Yanowitz, J. L., & Rajkovic, A. (2020) · Prenatal Diagnosis · doi:10.1002/pd.5838 · Cited by 29
“High resolution copy number analysis may aid in detection of cryptic chromosomal imbalances in RPL [20-22].”
BackgroundRNA Sequencing of Decidua Reveals Differentially Expressed Genes in Recurrent Pregnancy Loss
Li, Y., Wang, R., Wang, M., Huang, W., Liu, C., Fang, Z., Liao, S., & Jin, L. (2021) · Reproductive Sciences · doi:10.1007/s43032-021-00482-w · Cited by 29
Cervicovaginal microbiome in patients with recurrent pregnancy loss
Mori, R., Hayakawa, T., Hirayama, M., Ozawa, F., Yoshihara, H., Goto, S., Kitaori, T., Ozaki, Y., & Sugiura‐Ogasawara, M. (2023) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2023.103944 · Cited by 28
Odendaal, J., Quenby, S. M., Sammaritano, L. R., Macklon, N., Branch, D. W., & Rosenwaks, Z. (2019) · Fertility and Sterility · doi:10.1016/j.fertnstert.2019.10.002 · Cited by 28
Girardi, L. D. C., Patassini, C., Miravet-Valenciano, J., Sato, Y., Cagnin, N. F., Castellón, J. A., Cogo, F., Zambon, P., Blesa, D., Almazán, J. J., et al. (2024) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-024-03278-4 · Cited by 23
“Of note, triploidy represents one of the most frequent chromosome abnormalities detected in early pregnancy losses, ranging from 9–10% in products of conception analysis [16, 28] to 13.1% in chorionic villus sampling [29] from natural conceptions.”
InfluentialRecurrent pregnancy loss: a committee opinion
Gracia, C. R., Amato, P., Anderson, J., Flyckt, R. L., Hansen, K., Hill, M., Jain, T., Jindal, S., Kalra, S., Pier, B. D., et al. (2026) · Fertility and Sterility · doi:10.1016/j.fertnstert.2026.03.001 · Cited by 27
Genetic testing of products of conception in recurrent pregnancy loss evaluation
Dahdouh, E. M., & Kutteh, W. H. (2021) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2021.03.015 · Cited by 23
Self-citationSATO, T. A., Sugiura‐Ogasawara, M., Ozawa, F., Yamamoto, T., Kato, T., Kurahashi, H., Kuroda, T., Aoyama, N., Kato, K., Kobayashi, R., et al. (2020) · Human Reproduction · doi:10.1093/humrep/dez289 · Cited by 22
Li, S., Chen, M., & Zheng, P. (2021) · Scientific Reports · doi:10.1038/s41598-021-98606-4 · Cited by 26
Li, S., Zheng, P., Ma, H. M., Feng, Q., Zhang, Y. R., Li, Q. S., He, J. J., & Liu, W. F. (2022) · Fertility and Sterility · doi:10.1016/j.fertnstert.2022.08.008 · Cited by 22
Zhou, M., Yue, G., Wu, S., Chen, J., Ding, J., Wang, Y., & Yang, J. (2023) · Biology of Reproduction · doi:10.1093/biolre/ioad053 · Cited by 21
“The causes of RSA are known to include chromosomal abnormalities, anatomical malformation, autoimmune diseases, endocrine disorders, and infection [2, 3].”
BackgroundGenetic findings in miscarriages and their relation to the number of previous miscarriages
Gomez, R., Hafezi, N., Amrani, M., Schweiger, S., Dewenter, M., THOMAS, P. A., Lieb, C., Hasenburg, A., & Skala, C. (2020) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-020-05859-x · Cited by 22
Chen, L., Wang, L., Tang, F., Zeng, Y., Yin, D., Zhou, C., Zhu, H., Li, L., Zhang, L., & Wang, J. (2021) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-021-02243-9 · Cited by 20
“As the underlying cause of pregnancy loss is complex, an etiologic analysis is essential and provides important information for medical management, reproductive counseling, and supportive patient care [1, 8].”
BackgroundNon‐coding RNAs and their cross‐talks impacting reproductive health of women
Jain, N., Gupta, P., Sahoo, S., & Mallick, B. (2021) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1695 · Cited by 20
“The congenital and acquired uterine anomalies, autoimmune factors, endocrine imbalance, chromosomal abnormalities are identified as the possible causes in 50% of RPL patients (Popescu et al., 2018).”
BackgroundCrosstalk between Placental Trophoblast and Decidual Immune Cells in Recurrent Miscarriage
Liu, Z., Tang, Y., Zhang, X., Pei, J., Wang, C., Liu, H., Yu, Y., Shouling, L. U. O., & Gu, W. (2023) · International Journal of Medical Sciences · doi:10.7150/ijms.86533 · Cited by 20
“Recurrent miscarriage is defined as the consecutive loss of two or more clinical pregnancies and affects approximately 2-5% of couples of reproductive ages [1, 2].”
BackgroundRole of genetic analysis of products of conception and PGT in managing early pregnancy loss
Kutteh, W. H., Papas, R. S., Maisenbacher, M. K., & Dahdouh, E. M. (2023) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2023.103738 · Cited by 21
Self-citationTamura, Y., Santo, M., Araki, Y., Matsubayashi, H., Takaya, Y., Kitaya, K., Doshida, M., Yamaguchi, K., Mizuta, S., Takahashi, C., et al. (2020) · Reproductive Medicine and Biology · doi:10.1002/rmb2.12351 · Cited by 19
Li, X., Li, W., Jia, H., Gao, Y., Shi, W., & Bai, H. (2022) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.14355 · Cited by 19
Miscarriage chromosome testing: Indications, benefits and methodologies
McQueen, D. B., & Lathi, R. B. (2018) · Seminars in Perinatology · doi:10.1053/j.semperi.2018.12.007 · Cited by 19
Rao, H., Zhang, H., Zou, Y., Ma, P., Huang, T., Yuan, H., Zhou, J., Wan, L., Li, Q., Huang, S., et al. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1248755 · Cited by 18
“Previous studies have found that 2%– 4% of RSA couples carry chromosomal abnormalities (Fryns and Van Buggenhout, 1998; Popescu et al., 2018), but the actual number of chromosomal variants undetectable by routine karyotyping is much higher than that (Dong et al.”
Australasian Recurrent Pregnancy Loss Clinical Management Guideline 2024 Part I
Suker, A., Li, Y., Robson, D., Marren, A. J., & the Australasian CREI (Certificate of Reproductive Endocrinology and Infertility) Consensus Expert Panel on Trial Evidence (ACCEPT) group (2024) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/ajo.13821 · Cited by 18
Abnormal ciliogenesis in decidual stromal cells in recurrent miscarriage
Hassan, E., Kojima, R., Ozawa, F., Yoshihara, H., Goto, S., Kitaori, T., Inagaki, H., Kato, Y., & Sugiura‐Ogasawara, M. (2022) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2022.103486 · Cited by 17
Wang, Y., Zhou, R., Jiang, L., Meng, L., Tan, J., Qiao, F., Wang, Y., Zhang, C., Cheng, Q., Jiang, Z., et al. (2020) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2020.10.002 · Cited by 16
Liu, M., Sun, X., Zhu, L., Zhu, M., Deng, K., Nie, X., Mo, H., Du, T., Huang, B., Hu, L., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.717785 · Cited by 15
Balaguer, N., Rodrigo, L., Mateu, E., Campos‐Galindo, I., Castellón, J. A., Al‐Asmar, N., Rubio, C., & Milán, M. (2023) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.17629 · Cited by 16
Yao, Y., Fan, H., Tang, L.-C., Xu, X., & Jin, L. (2020) · Molecular Human Reproduction · doi:10.1093/molehr/gaaa035 · Cited by 15
Levothyroxine and subclinical hypothyroidism in patients with recurrent pregnancy loss
Yoshihara, H., Sugiura‐Ogasawara, M., Goto, S., & Kitaori, T. (2020) · American Journal of Reproductive Immunology · doi:10.1111/aji.13341 · Cited by 14
The association between chronic deciduitis and recurrent pregnancy loss
Goto, T., Goto, S., Ozawa, F., Yoshihara, H., Kitaori, T., Komura, M., Takahashi, S., Ozaki, Y., & Sugiura‐Ogasawara, M. (2023) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2023.103824 · Cited by 13
Sierra, S., Min, J. K., Saumet, J., Shapiro, H. M., Sylvestre, C. V., Roberts, J., Liu, K. E., Buckett, W. M., Vélez, M. P., & MAHUTTE, N. G. (2024) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2024.104456 · Cited by 16
Associations of mitochondrial DNA copy number and deletion rate with early pregnancy loss
Ye, M., Shi, W., Hao, Y., Zhang, L., Chen, S., Wang, L., He, X., Li, S., & Xu, C. (2020) · Mitochondrion · doi:10.1016/j.mito.2020.07.006 · Cited by 12
Gu, C., He, Y., Li, X., Li, Q., Xuan, Q., & Li, K. (2022) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-022-06776-x · Cited by 12
“It is well known that over half of the early miscarriages are caused by chromosomal abnormalities such as aneuploidy[3, 23].”
BackgroundHui, L., Poulton, A., Kluckow, E., Lindquist, A., Hutchinson, B., Pertile, M. D., Bonacquisto, L., Gugasyan, L., Kulkarni, A., Harraway, J. R., et al. (2020) · Human Reproduction · doi:10.1093/humrep/dez286 · Cited by 12
Mehta, P., Vishvkarma, R., Singh, K., & Rajender, S. (2021) · Reproductive Sciences · doi:10.1007/s43032-021-00530-5 · Cited by 14
Advances in the management of early pregnancy loss
Henkel, A., & Shaw, K. A. (2018) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0000000000000501 · Cited by 11
Expanding the role of chromosomal microarray analysis in the evaluation of recurrent pregnancy loss
Eliwa, J., Papas, R. S., & Kutteh, W. H. (2023) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2023.104188 · Cited by 10
Self-citationDanaparoid is effective and safe for patients with obstetric antiphospholipid syndrome
Yoshihara, H., Sugiura‐Ogasawara, M., Kitaori, T., Katano, K., & Ozaki, Y. (2019) · Modern Rheumatology · doi:10.1080/14397595.2019.1602241 · Cited by 10
“A recent aCGH analysis showed a higher rate of abnormal embryonic karyotypes [33].”
BackgroundLou, Y., Chen, G., Wang, L., Zhao, X., & Ma, J. (2024) · Scientific Reports · doi:10.1038/s41598-024-81759-3 · Cited by 9
Characteristic DNA methylation profiles of chorionic villi in recurrent miscarriage
Matsumoto, Y., Shinjo, K., Mase, S., Fukuyo, M., Aoki, K., Ozawa, F., Yoshihara, H., Goto, S., Kitaori, T., Ozaki, Y., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-15656-y · Cited by 9
Zhao, X., Zhao, Y., Yang, Q., Ma, J., Zhao, Y., Wang, S., Jiang, Y., & Zhang, Q. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2024.119675 · Cited by 9
Two kinds of embryo research: four case examples
Savulescu, J., Labude, M. K., Barcellona, C., Huang, Z., Leverentz, M. K., Xafis, V., & Lysaght, T. (2022) · Journal of Medical Ethics · doi:10.1136/medethics-2021-108038 · Cited by 9
PGT-A for recurrent pregnancy loss: evidence is growing but the issue is not resolved
Dahdouh, E. M., Balayla, J., García-Velasco, J. A., & Kutteh, W. H. (2021) · Human Reproduction · doi:10.1093/humrep/deab194 · Cited by 9
Self-citationGenetic analysis of products of conception. Should we abandon classic karyotyping methodology?
Christofolini, D. M., Bevilacqua, L. B., Mafra, F., Kulikowski, L. D., Bianco, B. A. V., & Barbosa, C. P. (2021) · Einstein (São Paulo) · doi:10.31744/einstein_journal/2021ao5945 · Cited by 8
“The failure rate of cell culture for karyotype analysis verified in this study (10%) is slightly different from the rate of 12% to 21% described in the literature.(2,14) Thirteen cases randomly selected were reevaluated by the CMA in another research laboratory.”
ResultZhu, Y., Zhang, Z., Ma, Z., Deng, W., Zhang, Y., & Wu, Q. (2022) · Molecular Reproduction and Development · doi:10.1002/mrd.23654 · Cited by 9
“Numerous studies have reported that implantation failure occurred due to embryo aneuploidy, endocrine disorders, uterine abnormalities, endometritis, thrombophilia, autoimmune diseases, and microbial infections (Ewington et al., 2019; Popescu et al., 2018), with a few of the patients experiencing recurrent implantatio…”
BackgroundMechanisms of YAP1-mediated trophoblast ferroptosis in recurrent pregnancy loss
Chen, L., Dai, F., Huang, Y., Chen, J., Li, Z., Liu, H., & Cheng, Y. (2024) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-024-03096-8 · Cited by 8
“Some factors are considered to be the etiology of RPL, including genetic factors [2], chromosomal [3] and uterine anatomic abnormalities [4], infections [5], antiphospholipid syndrome [6], endocrine abnormalities [7, 8], and inherited thrombophilias [9].”
Jiang, Y., Zou, Q., Zhang, N., Chen, J., Chen, X., You, Q., & Wu, H. (2022) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.13771 · Cited by 8
“Moreover, limited management options for RSA patients also impair their long-term physical health.(5,6) Recent studies show that RSA is linked with an unbalanced immune cell profile causing inflammatory/immune dysregulation in the uterine environment.”
BackgroundZhang, L., Yang, Y., Wang, W., Luo, L., Zhang, Z., Wu, J., Ou, S., Mai, J., Guo, L., Wan, J., et al. (2023) · Human Reproduction · doi:10.1093/humrep/dead202 · Cited by 8
Hawkes, A., Shields, R. C., Quenby, S. M., Bick, D., Parsons, J., & Harris, B. (2023) · BMJ Open · doi:10.1136/bmjopen-2023-075062 · Cited by 9
Peng, S., Bhatt, S., BORRELL, A., & Yaron, Y. (2021) · Prenatal Diagnosis · doi:10.1002/pd.5972 · Cited by 8
“In some RPL cases, the miscarriage could be due to more than one etiology(10,13) A scenario analysis was conducted to compare the diagnostic yield across various testing pathways assuming alternative etiology distribution as reported in study by Popescu and colleagues.(13) In real‐world practice, RPL cases may receive…”
BackgroundAntiphospholipid Antibodies in Pregnancy: Maternal and Neonatal Implications
Gris, J., Guillotin, F., Chéa, M., Bourguignon, C., Cochery-Nouvellon, É., & Bouvier, S. (2022) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0042-1756193 · Cited by 10
Shen, X., Chen, D., Ding, C., Xu, Y., Fu, Y., Cai, B., Wang, Y., Wang, J., Li, R., Guo, J., et al. (2022) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-022-02447-7 · Cited by 8
Korkidakis, A., Albert, A., Jiang, I., Terry, J., AbdelHafez, F. F., & Bedaiwy, M. A. (2023) · Reproductive Sciences · doi:10.1007/s43032-023-01239-3 · Cited by 6
Zhao, S., Lyu, C., Liu, Y., Wang, X., Zhang, Z., Lv, H., Ni, T., & Yan, J. (2024) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003041 · Cited by 6
Yoshihara, H., Sugiura‐Ogasawara, M., Ozawa, F., Kitaori, T., Ozaki, Y., Aoki, K., Shibata, Y., Ugawa, S., Nishiyama, T., Omae, Y., et al. (2020) · Human Genome Variation · doi:10.1038/s41439-020-0106-2 · Cited by 6
The Value of Parental Karyotyping in Recurrent Pregnancy Loss Lies in Individual Risk Assessments
Popescu‐Hobeanu, G., Sosoi, S. S., Cucu, M., Streață, I., Dobrescu, A., Pleşea, I. E., Costache, A. L., Iordache, A., Petre-Mandache, B., Tudorache, Ş., et al. (2024) · Medicina · doi:10.3390/medicina60111778 · Cited by 5
HMGB1 induces unexplained recurrent spontaneous abortion by mediating decidual macrophage autophagy
Han, X., Ren, Y., Zhang, X., Zhu, D., Meng, Z., Zhang, Q., Chen, B., Zhou, P., Wei, Z., Cao, Y., et al. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113999 · Cited by 5
Zhang, L., Du, Y., Zhou, J., Liu, C., Li, J., & Qiao, C. (2025) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-025-07330-8 · Cited by 5
“Propescu et al. found that 24 chromosome microarray analysis of pregnancy loss tissue combined with ASRM assessment of pregnancy loss accounts for almost 95% of cases of recurrent pregnancy loss [26].”
Ouchi, N., Takeshita, T., Kasano, S., Yokote, R., Yonezawa, M., Kurashina, R., Ichikawa, T., Kawabata, I., & Kuwabara, Y. (2021) · Journal of Nippon Medical School · doi:10.1272/jnms.jnms.2022_89-103 · Cited by 5
Preimplantation Genetic Testing
Yatsenko, S. A., & Rajkovic, A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-815236-2.00007-2 · Cited by 5
Song, C., & Shang, W. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-981-33-4187-6_12 · Cited by 6
Bremm, J. M., Boquett, J. A., Michels, M., Kowalski, T. W., Gomes, F. G., Vianna, F. S. L., Sanseverino, M. T. V., & Fraga, L. R. (2021) · Systems Biology in Reproductive Medicine · doi:10.1080/19396368.2021.1965673 · Cited by 5
“Genetic variants and alterations in cytokine levels of the TGF-β family were already associated to RPL (Prakash et al. 2005; Magdoud et al. 2013; Mazdapour et al. 2018).”
BackgroundUpdate on preimplantation genetic testing for aneuploidy and outcomes of embryos with mosaic results
Dahdouh, E. M., Mourad, A., Balayla, J., Sylvestre, C. V., Brezina, P. R., Kutteh, W. H., Picchetta, L., Capalbo, A., & García-Velasco, J. A. (2022) · Minerva Obstetrics and Gynecology · doi:10.23736/s2724-606x.22.05166-1 · Cited by 5
Self-citationCell-Free DNA Analysis of Fetal Aneuploidies in Early Pregnancy Loss
Kutteh, W. H., Miller, C. E., Park, J. K., Corey, V. C., Chavez, M., Racicot, K. E., Alagia, D. P., Jinnett, K. N., Curnow, K. J., Dalton, K., et al. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13154283 · Cited by 6
“This workup can be expensive and time-consuming, and it only identifies a probable cause for RPL in around half of patients [11].”
BackgroundSelf-citationChromosomal miscarriage and pregnancy outcomes in recurrent pregnancy loss
Yang, Y., Zhang, X., Zhang, Y., Ou, M., Wang, C., Lu, Y., Luo, L., & Wang, Q. (2025) · Reproduction and Fertility · doi:10.1530/raf-25-0052 · Cited by 4
Du, M., Gu, H., Li, Y., Huang, L., Gao, M., Xu, H., Deng, H., Zhong, W., Liu, X., & Zhong, X. (2022) · Open Life Sciences · doi:10.1515/biol-2022-0518 · Cited by 4
“Factors known to lead to RSA include abnormal chromosome karyotypes of parents or embryos, abnormal uterine anatomy, endocrine and metabolic abnormalities, infec - tious diseases, antiphospholipid syndrome, and envir - onmental factors [ 4,5 ] .”
Qian, C., Pan, C., Liu, J., Wu, L., Pan, J., Liu, C., & Zhang, H. (2023) · Human Immunology · doi:10.1016/j.humimm.2023.110745 · Cited by 4
Genetics and genomics of recurrent pregnancy loss
Kasak, L., Rull, K., & Laan, M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91380-5.00012-5 · Cited by 6
de Oliveira, E. C. F., Cruzeiro, I. K. D. C., de Souza, C. A. A., & dos Reis, F. M. (2024) · Revista Brasileira Ginecologia e Obstetrícia · doi:10.61622/rbgo/2024rbgo51 · Cited by 4
“(6,7) Maternal age is a well-known risk factor for sporadic mis-carriage, as well as for RPL. Women over the age of 35 have an increased rate of meiotic errors in oocyte development leading to increased embryonic aneuploidy.”
BackgroundYe, Q., Liu, F., Xia, X.-J., Chen, X., Zou, L., Wu, H., Li, D.-D., Xia, C.-N., Huang, T., Cui, Y., et al. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1462649 · Cited by 3
Stavros, S., Mavrogianni, D., Ntetsika, L., & Drakakis, P. (2022) · Hellenic Journal of Obstetrics and Gynecology · doi:10.33574/hjog.0402 · Cited by 5
Advances of Genetic Testing Technology in Etiology Diagnosis of Recurrent Spontaneous Abortion
Xiao, Q., Li, Z., & Lu, J. (2023) · Yangtze Medicine · doi:10.4236/ym.2023.72008 · Cited by 3
ACCEPT Group Condensed Position Paper on the Management of Recurrent Pregnancy Loss
Suker, A., Li, Y., Marren, A. J., Robson, D., & the Australasian CREI (Certificate of Reproductive Endocrinology and Infertility) Consensus Expert Panel on Trial evidence (ACCEPT) Group (2025) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/ajo.70001 · Cited by 3
“If available, products of conception (POC) tissue should be analysed using molecular methods (array-CGH or SNP array) to assess for aneuploidy, which can confirm chromosomal abnormalities in about two-thirds of pregnancy loss cases [5].”
Reproductive immunology from the perspective of the clinician
Scott, J. R. (2019) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2019.05.002 · Cited by 3
Early and recurrent pregnancy loss
Turocy, J. M., & Williams, Z. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-65399-2.00025-5 · Cited by 4
Metadata
- Authors
- Popescu, F., Jaslow, C. R., & Kutteh, W. H.
- Affiliations
- Rhodes College (US)
- St. Jude Children's Research Hospital (US)
- Corresponding author
- Kutteh, W H
- Venue
- Human Reproduction
- Publisher
- Oxford University Press (OUP)
- Published
- 2018-03-12
- Volume
- 33
- Issue
- 4
- Pages
- 579-587
- ISSN
- 0268-1161 (ISSN-L)
- 1460-2350
- OpenAlex
- W2794293654
- Cited by
- 141
- References
- 46
- Citations by year
- 2026: 9 · 2025: 13 · 2024: 17 · 2023: 28 · 2022: 19 · 2021: 20 · 2020: 18 · 2019: 10 · 2018: 7
- FWCI
- 5.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Human Reproduction (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Reproductive System and Pregnancy
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Screening and Diagnostics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Reproductive Health and Contraception
- Keywords
- recurrent pregnancy loss, miscarriage, uterine anomalies, antiphospholipid syndrome, lupus anticoagulant, anticardiolipin antibodies, thyroid function, prolactin, cost analysis, diagnostic yield, endometrial receptivity
- MeSH terms
- Abortion, Habitual, Adult, Chromosome Aberrations, Female, Genetic Testing, Humans, Karyotyping, Maternal Age, Middle Aged, Pregnancy, Pregnancy Outcome, Prospective Studies, Tissue Array Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.